17
Participants
Start Date
January 10, 2023
Primary Completion Date
February 20, 2024
Study Completion Date
February 20, 2024
Radiofrequency ablation (RFA)
The NEUROMARK device is an in-office, disposable bipolar RFA device with a treatment tip consisting of micro electrodes which delivers RF energy while monitoring appropriate tissue contact to maximize delivery to posterior nasal nerve and its variable branching. After topical anesthesia consisting of oxymetazoline and 1% lido followed by 4% lidocaine, the device will be placed in the posterior inferior turbinate under endoscopic visualization. The device will be activated per manufacturer's instructions
The University of Texas Health Science Center at Houston, Houston
American Academy of Otolaryngic Allergy
OTHER
The University of Texas Health Science Center, Houston
OTHER